logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for business professionals · Wednesday, March 11, 2026 · 898,617,949 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Patents & Trademarks News  •••  Topics  •  Countries  •  U.S. States

Gene Patent News Monitoring

  • Published on Mar 9, 2026

    Single-Dose CAR-Astrocyte Therapy Shows Promise for Alzheimer’s Disease

    The new generation of Alzheimer’s disease drugs — the first proven to change the course of the disease — typically extend independent living for patients by 10 months. Called monoclonal antibodies, they reduce the accumulations of a harmful protein, …

    Source: Technology Networks - Neutral
  • Published on Feb 16, 2026

    Tango mandarin patent expires, granting US growers royalty-free access

    By Carla Espinoza Gutiérrez United States growers have gained open, royalty-free access to one of California’s most valuable mandarin cultivars following the expiration of the Tango plant variety patent. This puts an end to nearly two decades of domestic …

    Source: Fresh Fruit Portal - Neutral
  • Published on Feb 10, 2026

    Human cloning excluded from patentable subjects in Azerbaijan

    Human cloning will not be recognized as a patentable subject, APA reports. This is reflected in an amendment to the Law “On Patents” that was discussed at today’s session of the Milli Majlis. Under the draft law, methods of human cloning and human clones, …

    Source: APA - Gov't Propaganda
  • Published on Mar 7, 2026

    From orchard to market: Columbia Fruit Packers demonstrates apple production, export

    Behind the doors at Columbia Fruit Packers, the air felt different: cooler, metallic, alive with motion. Apples were everywhere and nowhere at once: floating in water, rolling under cameras, disappearing into boxes and bags bound for places far beyond the …

    Source: The Columbian - Washington State - Neutral
  • Published on Mar 7, 2026

    Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2025 Earnings Call Transcript

    Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2025 Earnings Call Transcript March 5, 2026 Lineage Cell Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.004, expectations were $-0.04333. Operator: Welcome to the Lineage Cell Therapeutics …

    Source: Insider Monkey - Neutral
  • Published on Mar 6, 2026

    After Migraine, Screen for Depression and Anxiety

    TOPLINE:  Patients with migraine had a higher risk of developing depression or anxiety than individuals without migraine, and this elevated risk persisted after accounting for shared genetic factors and childhood family environments; however, small area …

    Source: Medscape - Neutral
  • Published on Feb 10, 2026

    New Molecule Blocks Deadliest Brain Cancer at Its Genetic Root

    Scientists have uncovered a promising strategy for tackling glioblastoma by targeting a gene that appears to be essential for the cancer’s survival. Using laboratory models, the team identified a small molecule capable of shutting down this gene’s activity …

    Source: SciTechDaily - Neutral
  • Published on Mar 8, 2026

    Gut drug boosts liver health in mice after small bowel surgery

    Researchers at Washington University have developed a gut-specific drug that protects the liver and improves nutrient absorption in mice after small bowel surgery. Surgical removal of diseased or damaged sections of the small intestine, known as radical …

    Source: Drug Target Review - Neutral
  • Published on Mar 5, 2026

    Researchers trialling simple oral medicines to combat dementia in diabetes

    Curtin University researchers will investigate a promising new approach to preventing cognitive decline and dementia in people living with diabetes, after winning a prestigious Diabetes Australia Research Grant. Led by Associate Professor Ryu Takechi from …

    Source: Curtin University - Pending
  • Published on Mar 5, 2026

    Novartis settles with Henrietta Lacks estate over use of her ‘stolen’ cells to advance medicine

    Not possible without you! Our journalism is only possible with support from you, our readers. The news mainstream media just doesn’t cover. Racial justice journalism since 1909. Sign up for our FREE acclaimed newsletters! The news mainstream media just …

    Source: Amsterdam News - New York - Pending
  • Published on Mar 4, 2026

    Novartis Settles With Henrietta Lacks’ Estate 

    By Brian Witte, Associated Press Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to …

    Source: The San Diego Voice and Viewpoint - California - Pending
  • Published on Mar 7, 2026

    Early CAR-Astrocyte Therapy Prevents Plaque Formation in Alzheimer’s Mouse Model

    Researchers at Washington University School of Medicine in St. Louis have developed genetically altered astrocytes that express chimeric antigen receptors (CARs) as a promising immunotherapy system capable of clearing accumulations of amyloid-β (Aβ)—a …

    Source: Genetic Engineering & Biotechnology News -New York - Pending
  • Published on Mar 6, 2026

    Single dose of CAR-astrocyte therapy halves amyloid levels in mice brains

    The new generation of Alzheimer's disease drugs - the first proven to change the course of the disease - typically extend independent living for patients by 10 months. Called monoclonal antibodies, they reduce the accumulations of a harmful protein, …

    Source: Medical News - Neutral
  • Published on Mar 6, 2026

    Single-Injection Immunotherapy That Halts Alzheimer’s

    Summary: Current Alzheimer’s treatments typically require frequent, high-dose infusions of monoclonal antibodies to slow cognitive decline. But researchers have engineered a potentially game-changing alternative: CAR-astrocytes. Taking inspiration from CAR …

    Source: Neuroscience News - Texas - Pending
  • Published on Mar 4, 2026

    The 2026 Biologics Wave: Which Innovations Will Break Through?

    The biopharmaceutical landscape continues to evolve at a remarkable pace, driven by breakthroughs in targeted therapies, novel modalities, and a deepening understanding of disease mechanisms. As we approach 2026, the anticipated approvals of innovative …

    Source: Contract Pharma - Neutral
  • Published on Mar 6, 2026

    New compound shows promise in protecting the liver from damage after small bowel surgery

    When parts of the small intestine are diseased or die, the treatment can involve surgically removing the affected tissue. Although lifesaving, the procedure - referred to as a radical small bowel resection - can lead to long-term liver damage and even …

    Source: Medical News - Neutral
  • Published on Feb 25, 2026

    REGENEXBIO Inc. v. Sarepta Therapeutics, Inc. (Fed. Cir. 2026)

    A consequence of the Supreme Court’s assault on subject matter eligibility a dozen years or so ago was that the patent defense bar presented the judiciary with ever more stringent standards and extreme if not fanciful positions that resulted in …

    Source: JD Supra - California - Neutral
  • Published on Feb 28, 2026

    Living on borrowed time: Tremendous cost of rare diseases in India

    Revathi B, an engineering student in Bengaluru, hopes to turn 19 this April — if she lives to see it. Diagnosed with the most severe form of Gaucher disease, a rare genetic disorder that often claims lives in early childhood, every year she has survived …

    Source: India Today - Neutral
  • Published on Mar 4, 2026

    From Coffee to Wine, Amatera Raises $7M to Expand AI-Led Tech for Climate-Resilient Crops

    5 Mins Read French agtech startup Amatera has closed a €6M ($7M) seed funding round to expand its AI-powered plant cell biology platform for climate-resilient crops, starting with coffee and wine grapes. Two of the world’s favourite beverages are facing …

    Source: Green Queen - Left-wing

06 days 01:40:50

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more patents & trademarks news or search news using your own keywords. There are 898,617,949 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Patents & Trademarks News by Country >
Patents & Trademarks News by U.S. State >
Patents & Trademarks News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 02/12/2026

World Media Directory >

Law Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Law Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Patents and Trademarks Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow EIN Presswire on Facebook, LinkedIn and Substack

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2026 Newsmatics Inc. · All Rights Reserved · General Terms & Conditions · Privacy Policy · Cookie Settings

By continuing to use this site, you agree to our Terms & Conditions, last updated on September 30, 2025.